Nicotine Vaccination and Nicotinic Receptor Occupancy

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Nicotine Dependence
Interventions
BIOLOGICAL

NicVAX

1.0 mL of Nicotine Conjugate Vaccine(x4), I.M. at 3 week intervals between SPECT studies

RADIATION

[123I]5-IA-85380

up to 10 mCi of \[123I\]5-IA-85380, I.V. on each of two SPECT Scan days

DRUG

Nicotine bitartrate

0.5-1.5 mg of Nicotine bitartrate, I.V. on each of two SPECT Scan days

Trial Locations (1)

06516

Veterans Association Connecticut Hospital System, West Haven

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Nabi Biopharmaceuticals

INDUSTRY

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER

NCT00996034 - Nicotine Vaccination and Nicotinic Receptor Occupancy | Biotech Hunter | Biotech Hunter